BFAM vs BIO
BRIGHT HORIZONS FAMILY SOLUTIONS INC. vs BIO-RAD LABORATORIES, INC. — Side-by-Side Stock Comparison
BFAM
BRIGHT HORIZONS FAMILY SOLUTIONS INC.
8.4
Strong Buy
$68.25
BIO
BIO-RAD LABORATORIES, INC.
4.0
Weak
$282.01
BFAM vs BIO: Which is the Better Investment?
BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) scores 8.4/10 while BIO-RAD LABORATORIES, INC. (BIO) scores 4.0/10 on AlphaStocks' composite model. BRIGHT HORIZONS FAMILY SOLUTIONS INC. has the higher composite rating of Strong Buy. On a P/E basis, BIO-RAD LABORATORIES, INC. trades at 10.1x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | BFAM | BIO |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 8.4/10▲ | 4.0/10 |
| Rating | Strong Buy▲ | Weak |
| Price | $68.25 | $282.01 |
| P/E Ratio | 20.3 | 10.1▲ |
| ROE | 14.0%▲ | 9.7% |
| Market Cap | $4B | $8B |
| Fair Value | $64.30 | — |
| Dividend Yield | — | — |
| Sector Rank | #1 of 1125▲ | #859 of 1125 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Strong▲ | Neutral |
| Graham | Caution | Attractive▲ |
| Lynch | Neutral | Attractive▲ |
| Greenblatt | Attractive | Strong▲ |
BFAM vs BIO: Which Stock Scores Higher?
BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) and BIO-RAD LABORATORIES, INC. (BIO) are among the most compared stocks in the S&P 500. BFAM currently leads with a composite score of 8.4/10 (Strong Buy) compared to BIO's 4.0/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer